Limitations in medicaid coverage of biologics for the treatment of hidradenitis suppurativa
Crossref DOI link: https://doi.org/10.1007/s00403-024-03371-9
Published Online: 2024-09-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arora, Neha
Skaggs, Elena
Bicknell, Lindsay
Text and Data Mining valid from 2024-09-14
Version of Record valid from 2024-09-14
Article History
Received: 19 August 2024
Revised: 19 August 2024
Accepted: 3 September 2024
First Online: 14 September 2024
Declarations
:
: The authors declare no competing interests.
: None.